Is reverse total shoulder arthroplasty (rTSA) more advantageous than anatomic TSA (aTSA) for osteoarthritis with intact cuff tendon? A systematic review and meta-analysis

Kim, Hyojune; Kim, Chul-Ho; Kim, Minsoo; Lee, Wonsun; Jeon, In-Ho; Lee, Kwang Won; Koh, Kyoung Hwan

doi:10.1186/s10195-022-00625-y

Journal of Orthopaedics and Traumatology

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 1 Studies included in the meta-analysis

From: Is reverse total shoulder arthroplasty (rTSA) more advantageous than anatomic TSA (aTSA) for osteoarthritis with intact cuff tendon? A systematic review and meta-analysis

Study	Procedure (cases)	Prosthetic	Age, years	Follow-up time, months ± SD (range)	Outcome measures	Study design	Evidence level	MINORS score
Gallusser et al. [8]	rTSA (8)	Tornier, Edina, MN, USA	79 (73–85)	43 (24–69)	SSV (%), QuickDASH, SST, Constant score, ROM, radiological radiolucent line grading, complications	Retrospective case series	IV	18
Gallusser et al. [8]	aTSA (19)	Tornier, Edina, MN, USA	66 (47–79)	57 (24–95)		Retrospective case series	IV	18
Steen et al. [23]	rTSA (24)	DJO Surgical, Austin, TX, USA	77.7 ± 8.0	42 (24–92)	ASES, SST, ROM, complications	Retrospective cohort design, treatment study	III	16
Steen et al. [23]	aTSA (96)	DJO Surgical, Austin, TX, USA	76.7 ± 8.0	49 (25–97)	ASES, SST, ROM, complications	Retrospective cohort design, treatment study	III	16
Alentorn-Geli et al. [1]	rTSA (16)	Biomet, Warsaw, IN, USA	72.5 ± 5.4	35.1 ± 14.2	ROM, PVAS, ASES, SST, patient satisfaction, complications	Retrospective cohort design, treatment study	III	16
Alentorn-Geli et al. [1]	aTSA (15)	Biomet, Warsaw, IN, USA Stryker, Mahwah, NJ, USA Smith and Nephew, Memphis, TN, USA	70.5 ± 7.5	42.7 ± 18.4	ROM, PVAS, ASES, SST, patient satisfaction, complications	Retrospective cohort design, treatment study	III	16
Haritinian et al. [10]	rTSA (12)	Aramis Reversed and Anatomical Total Shoulder Prostheses (3S Ortho, Lyon, France)	71 ± 11	> 24 months	ROM, Constant score, SSV, patient satisfaction	Retrospective cohort design, treatment study	III	16
Haritinian et al. [10]	aTSA (39)		68 ± 7.5	> 24 months	ROM, Constant score, SSV, patient satisfaction	Retrospective cohort design, treatment study	III	16
Wright et al. [27]	rTSA (33)		78	85	PVAS, patient satisfaction, ASES, WOOS, ROM	Retrospective cohort design, treatment study	III	16
Wright et al. [27]	aTSA (102)		77	85	PVAS, patient satisfaction, ASES, WOOS, ROM	Retrospective cohort design, treatment study	III	16
Merolla et al. [15]	rTSA (36)	Ascend Flex (Wright Medical, Memphis, TN, USA)	71.6 (68–72)	28.8 (27–30)	ROM, PVAS, Constant score, radiological outcomes	Retrospective cohort design, treatment study	III	16
Merolla et al. [15]	aTSA (47)	Ascend Flex (Wright Medical, Memphis, TN, USA)	71.6 (68–72)	28.8 (27–30)	ROM, PVAS, Constant score, radiological outcomes	Retrospective cohort design, treatment study	III	16

Back to article page